Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:17 PM
Ignite Modification Date: 2025-12-25 @ 7:05 PM
NCT ID: NCT00335504
Description: Common Toxicity Criteria for Adverse Events (CTCAE) v3
Frequency Threshold: 5
Time Frame: Start of treatment to 30 days past the end of treatment.
Study: NCT00335504
Study Brief: Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Arm III (Oligofructose-enriched Inulin) Patients receive 6gm powder oral oligofructose-enriched inulin (Raftilose Synergy 1) twice daily. None None 0 20 12 20 View
Arm I (Atorvastatin Calcium) Patients receive 20 mg tablet oral atorvastatin once daily. None None 0 22 15 22 View
Arm II (Sulindac) Patients receive 150 mg tablet oral sulindac twice daily. None None 0 21 14 21 View
Arm IV (Placebo) Patients receive an oral placebo (maltodextrin powder) twice daily. None None 0 22 19 22 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Constitutional Symptoms - Other Specify SYSTEMATIC_ASSESSMENT General disorders MedDRA (6.1) View
Auditory/Ear - Other Specify SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA (6.1) View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (6.1) View
Fever SYSTEMATIC_ASSESSMENT General disorders MedDRA (6.1) View
Bruising SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (6.1) View
Dermatology/Skin - Other Specify SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (6.1) View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (6.1) View
Endocrine - Other Specify SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA (6.1) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (6.1) View
Flatulence SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (6.1) View
Gastrointestinal - Other Specify SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (6.1) View
Heartburn SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (6.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (6.1) View
Infection - Other (Specify SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (6.1) View
Aspartate aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (6.1) View
Investigations - Other, specify SYSTEMATIC_ASSESSMENT Investigations MedDRA (6.1) View
Neuropathy: sensory SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (6.1) View
Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (6.1) View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (6.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (6.1) View
Joint Pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (6.1) View
Muscle Pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (6.1) View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (6.1) View
Dyspnea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (6.1) View
Pulmonary/Upper Respiratory - Other Specify SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (6.1) View